Noteworthy Thursday Option Activity: SIG, NVDA, APP

NVIDIA (NVDA) saw 2.1 million options contracts trade (~212.2 million underlying shares), roughly 103.5% of its one‑month average daily share volume (205.1M), led by 113,771 contracts in the $175 call expiring Dec. 19, 2025 (~11.4M underlying shares). Applovin (APP) registered 35,703 contracts (~3.6M underlying shares), about 92.7% of its one‑month average daily volume (3.9M), with notable flow in the $700 Dec. 19, 2025 call (1,476 contracts, ~147,600 shares); the activity signals concentrated speculative call positioning that could amplify near‑term volatility and intraday price moves.

Analysis

Market structure: Large directional call flow (113,771 NVDA $175 Dec‑19‑2025 contracts ≈11.4M shares, ~5.6% of NVDA 1‑month ADV) is likely creating mechanical buy pressure via market‑maker delta‑hedging over days/weeks, benefiting NVDA equity holders, prime brokers, and liquidity providers while amplifying short‑gamma pain for retail short sellers. APP’s concentrated $700 calls (≈147.6k shares, ~3.8% of ADV) signal speculative directional risk but on a materially smaller scale.

Risk assessment: Tail risks include export controls/US‑China restrictions or a wafer‑fab outage that could trigger >20–30% price gaps and cascade margin calls on crowded options positions; immediate (0–7 days) risk is gamma‑induced volatility, short‑term (30–90 days) risk is IV repricing ahead of earnings/macroeconomic moves, long‑term (6–24 months) depends on AI capex sustaining revenue — but counterparty concentration (prime brokers, option sellers) is a hidden lever.

Trade implications: Expect momentum continuation in the near term but elevated IV; prefer defined‑risk bullish exposure (e.g., buy Dec‑19‑2025 NVDA $175–$225 call spread) sized to 0.5–1.5% portfolio risk, or a relative play long NVDA / short AMD (ratio ~1:0.6) to isolate NVDA‑specific upside over 3–9 months. If IV rank >65 and realized vol < IV by >8ppt, consider selling tightly sized 30–45d put credit spreads (max 0.5% capital) to capture premium while limiting tail loss.

Contrarian angles: The market may be underestimating crowding and forced‑liquidity risk — heavy LEAP call concentration can flip to severe downside on IV spikes (historical parallel: 2020–21 mega‑cap call mania). Watch for rapid OI unwinds or IV spikes; if OI in the $175 Dec LEAP falls >40% in a week after a pullback, upside move may be exhausted and mean reversion likely.

Key Decisions for Investors

• Establish a defined‑risk long NVDA position: buy Dec‑19‑2025 NVDA $175/$225 call spread sized to risk 0.75% of portfolio (max loss = premium). Target 30–60% profit take within 6–12 months; if NVDA drops 12% intra‑position, reduce size by 50%.
• Execute a relative‑value pair: long NVDA (1% notional) vs short AMD (0.6% notional) to capture NVDA idiosyncratic upside while hedging semiconductor cyclicality; hold 3–9 months and rebalance on >10% divergence.
• If NVDA 30–45d IV rank >65 and IV > realized vol by >8 percentage points, sell 30–45d 1:1 OTM put credit spreads sized to 0.5% portfolio max exposure; cap single counterparty exposure and set hard stress loss limit of 6% on notional.
• Small speculative APP play: allocate 0.25–0.5% portfolio to buy APP Dec‑19‑2025 $700 calls only if post‑flow liquidity (ask/bid spread <2%) and position cost ≤ 0.5% of portfolio; target 12–18 month hold and do a 50% trim on >40% gain.
• Monitoring trigger: monitor NVDA Dec‑19‑2025 $175 OI and IV rank daily — if OI >120k and IV rank >65, increase vigilance (do not add long equity >0.5% without hedges). If OI falls >40% in 7 calendar days after a 5% price pullback, take at least 50% profits on NVDA exposures.